Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q4 2016
|
EIGR |
|
Phase 2 Results |
Other |
None |
|
Q4 2016
|
ACAD |
|
Phase 2 Results |
Neurology |
None |
|
Q4 2016
|
ACHN |
|
Phase 2 Results |
Other |
None |
|
H2 2016
|
ACOR |
|
Phase 3 Results |
Neurology |
None |
|
Q4 2016
|
DRNA |
|
Phase 1/2 Results |
Oncology |
None |
|
H2 2016
|
IMGN |
|
Phase 3 Results |
Oncology |
None |
|
H2 2016
|
ITCI |
|
Phase 3 Results |
Other |
None |
|
H2 2016
|
OXGN |
|
Phase 2 Results |
Oncology |
Orphan Drug |
|
Q4 2016
|
FLXN |
|
NDA Submission |
Other |
None |
|
Q4 2016
|
GALE |
|
Phase 2b Results |
Oncology |
None |
|